sodium hyaluronate 2 MG/ML Topical Foam [Bionect]

RxNorm concept 1596413, branded drug (sbd). Prescribable name: Bionect 0.2 % Topical Foam.

RxCUI: 1596413
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/1596413 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

hyaluronate 62372

Other names

Bionect 0.2 % Topical Foam; Bionect 2 MG/ML Topical Foam

Related concepts

sodium hyaluronate 2 MG/ML (SCDC, consists of)
sodium hyaluronate 2 MG/ML [Bionect] (SBDC, consists of)
Topical Foam (DF, has dose form)
Bionect (BN, has ingredient)
sodium hyaluronate 2 MG/ML Topical Foam (SCD, tradename of)

Linked data

NDCs

68712004601

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 1596413 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/1596413 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 1596413. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.